Hereditary diffuse gastric cancer: A family diagnosis and treatment

16Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Hereditary diffuse gastric cancer (HDGC) is a rare cancer representing approximately 2% of all gastric cancers. It is caused by CDH1 gene mutations, inherited in an autosomal dominant fashion, that affect the function of E-cadherin. Approximately 38% of HDGC families have a CDH1 gene mutation. With an estimated 75% penetrance rate, carriers are at high risk for HDGC. We describe the case of a Caucasian male of German-Russian ancestry, carrying a CDH1 gene mutation, who survived for 18 months after being diagnosed with HDGC. The results of genetic testing undergone by his family members are also reported, along with a review of the current literature. Since surveillance methods for HDGC are ineffective and unreliable, total prophylactic gastrectomy is advised for individuals with the gene mutation. Additionally, a diagnosis of HDGC should lead to genetic evaluation of family members followed by preventative measures. © 2013 Marshfield Clinic.

Cite

CITATION STYLE

APA

Onitilo, A. A., Aryal, G., & Engel, J. M. (2013). Hereditary diffuse gastric cancer: A family diagnosis and treatment. Clinical Medicine and Research, 11(1), 36–41. https://doi.org/10.3121/cmr.2012.1071

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free